This country profile provides an overview of Togo’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
100%
Blinding trachoma
N/A
Intestinal worms
100%
Bilharzia
100%
River blindness
50%
3.79 million people received treatment in Togo in 2017 1.59 million people did not receive treatment in Togo in 2017

Priorities for progress in Togo

  • Togo should work to further improve coverage rates for river blindness and consistently maintain annual high coverage implementation, in all risk groups, for bilharzia and intestinal worms.
  • It should clarify the trachoma situation and initiate treatments, or constitute an elimination dossier.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage was 100% in 2016 and 2017. Togo has eliminated elephantiasis as a public health problem.

People needing treatment
Eliminated
People receiving treatment
N/A

Blinding trachoma

Togo does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage increased from 68% in 2016 to 100% in 2017.

Pre-sch and school-aged children needing treatment
0.43m
Pre-school and school-aged children receiving treatment
0.43m

Bilharzia

Treatment coverage decreased from 94% in 2016 to 100% in 2017.

School-aged children needing treatment
1.71m
School-aged children receiving treatment
1.71m

River blindness

Treatment coverage decreased from 55% in 2016 to 50% in 2017.

People needing treatment
5.09m
People receiving treatment
2.54m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Togo.